Log in
Sign Up. It's Free
Last Update: Oct, 28 2024
Overview
Dosage & Administration
Drug label
Prior authorization
PubMed™ News
Patient education
FAQ
Parsabiv
(etelcalcetide)
DOSAGE FORMS & STRENGTHS
NO BOXED WARNING
Get Patient Education Material
Get Prior Authorization Forms
Dosage & Administration
* Ensure corrected serum calcium is at or above the lower limit of normal prior to initiation, dose increase, or re-initiation.
* The recommended starting dose is 5 mg administered by intravenous bolus injection three times per week at the end of hemodialysis treatment.
* The maintenance dose is individualized and determined by titration based on parathyroid hormone (PTH) and corrected serum calcium response. The dose range is 2.5 to 15 mg three times per week.
* The dose may be increased in 2.5 mg or 5 mg increments no more frequently than every 4 weeks.
* Measure serum calcium within 1 week after initiation or dose adjustment and every 4 weeks for maintenance.
* Measure PTH after 4 weeks from initiation or dose adjustment.
* Decrease or temporarily discontinue PARSABIV in individuals with PTH levels below the target range.
* Consider decreasing or temporarily discontinuing PARSABIV or use concomitant therapies to increase corrected serum calcium in patients with a corrected serum calcium below the lower limit of normal but at or above 7.5 mg/dL without symptoms of hypocalcemia.
* Stop PARSABIV and treat hypocalcemia if the corrected serum calcium falls below 7.5 mg/dL or patients report symptoms of hypocalcemia.
* Do not mix or dilute prior to administration.
* Administer by intravenous bolus injection into the venous line of the dialysis circuit after hemodialysis, during rinse back or intravenously after rinse back.
* Administer a sufficient volume of saline, e.g. 150 mL of rinse back, after injection into the dialysis tubing.
* If administered after rinse back, administer PARSABIV intravenously followed by at least 10 mL of saline flush.
Parsabiv Prescribing Information
Contact Medical Science Liaison
Report Adverse Event
Parsabiv Prior Authorization Resources
Most recent state uniform prior authorization forms
Verified: Oct 24, 2024
Arizona - Uniform Prior Authorization Form
Verified: Oct 24, 2024
Colorado - Uniform Prior Authorization Form
Verified: Oct 24, 2024
Hawaii - Uniform Prior Authorization Form
Verified: Oct 24, 2024
Illinois - Uniform Prior Authorization Form
Verified: Oct 24, 2024
Indiana - Uniform Prior Authorization Form
Verified: Oct 24, 2024
Louisiana - Uniform Prior Authorization Form
Verified: Oct 24, 2024
Minnesota - Uniform Prior Authorization Form
Verified: Oct 24, 2024
New Hampshire - Uniform Prior Authorization Form
Verified: Oct 24, 2024
New Mexico - Uniform Prior Authorization Form
Verified: Oct 24, 2024
Oregon - Uniform Prior Authorization Form
Verified: Oct 24, 2024
Texas - Uniform Prior Authorization Form
Verified: Oct 05, 2024
Washington - Uniform Prior Authorization Form
Verified: Oct 05, 2024
Wisconsin - Uniform Prior Authorization Form
Complete Letter of Medical Necessity
Parsabiv PubMed™ News
Last year
Publication date
Article Type
Format
5 articles
Reset Filters
Parsabiv Patient Education
To share resource; ask patient to:
1.
Pull out phone
2.
Open camera
3.
Scan QR code with camera
4.
Tap link
Patient toolkit
About Parsabiv
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Doctor Discussion Guide
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Brochure
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Getting To Know Your Treatment For sHPT Tearsheet
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Parsabiv FAQs
How is the dosage of Parsabiv?
Parsabiv is available in 3 dosages, including 5 mg/ml Injection 0.5 ml, 5 mg/ml Injection 1 ml and 5 mg/ml Injection 2 ml
What does Parsabiv treat?
Parsabiv treats Hyperparathyroidism, Secondary
What is Parsabiv made of?
Parsabiv contains etelcalcetide which is a Calcium-sensing Receptor Agonist
How Is Parsabiv Administered?
Parsabiv is administered as a Injectable
What Are The Parsabiv Mechanism Of Action?
Parsabiv mechanism of action is Increased Calcium-sensing Receptor Sensitivity
FAQ Data Source
We receive information directly from the FDA and PrescriberPoint is updated as frequently as change are made available